ArticleCureus2025
Glucose Transporter 1 (GLUT1) Positivity in Ganglion Cysts: A Diagnostic Caveat Due to Overlap With Perineuriomas and Other Fibromyxoid Lesions.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sclerosing perineurioma of the anterior chest wall in an active Caucasian toddler: a case report.Translational pediatrics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Glucose transporter 1 (GLUT1) is a sensitive immunohistochemical marker for perineural cells and certain mesenchymal neoplasms, including chordoma, desmoplastic small round cell tumor, desmoid-type fibromatosis, epithelioid sarcoma, gastrointestinal stromal tumor, myoepithelioma, schwannoma, and undifferentiated pleomorphic sarcoma. In this study, we focus on the morphological and immunohistochemical challenges in differentiating between ganglion cysts and perineuriomas. To our knowledge, no previous studies have explored the potential morphological and immunohistochemical similarities between these two lesions. We retrospectively retrieved cases coded as "ganglion cysts" from our departmental archives. Clinical data included the patient's age, gender, lesion location, and size. All slides were reviewed by two pathologists, and 4-μm-thick formalin-fixed paraffin-embedded tissue sections were subjected to immunostaining for epithelial membrane antigen (EMA) and GLUT1. The study included core biopsies and excision specimens from 14 patients (11 females and three males; M:F ratio: 3.6:1), ranging in age from 20 to 89 years (median: 60 years; mean: 53 years). Lesion locations included the finger (six cases), dorsal wrist (five cases), and the knee, volar wrist, and an unspecified hand site (one case each). Morphologically, 11 ganglion cysts were predominantly cystic, with walls composed of dense fibroconnective tissue and focal myxoid changes. These myxoid areas contained spindled and stellate cells within a myxoid stroma. The remaining three cases exhibited a predominantly solid morphology, characterized by dense fibroblastic-myofibroblastic stroma with limited myxoid degeneration and small spindled and bipolar cells. Scant chronic inflammation was observed in most cases. GLUT1 immunostaining showed membranous patterns in all cases, with some cytoplasmic expression, particularly in stellate cells within the myxoid matrix. EMA staining exhibited focal membranous expression in 12 cases (85.71%) and was negative in two cases (14.29%). These findings highlight the importance of caution when evaluating core biopsies of soft tissue lesions with bland cystic and fibromyxoid histology. The morphological and immunohistochemical similarities between ganglion cysts and perineuriomas may pose a diagnostic challenge and risk of misinterpretation. Awareness of these overlaps is crucial to avoid potential pitfalls in diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.